158 related articles for article (PubMed ID: 35293596)
1. Levels of circulating mast cell progenitors and tumour‑infiltrating mast cells in patients with colorectal cancer.
Zhao P; Zhou P; Tang T; Si R; Ji Y; Hu X; Li A; Jiang Y
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35293596
[TBL] [Abstract][Full Text] [Related]
2. Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis.
Liu X; Li X; Wei H; Liu Y; Li N
Front Immunol; 2023; 14():1209056. PubMed ID: 37497234
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis and Mast Cells in Colorectal Lesions: Significance in Adenoma-Colorectal Cancer Sequence and Association with Diet.
Alves IS; Coser PH; Loureiro GJ; Nogueira da Gama LP; Ribeiro Fda S; Bautz WG; Coburn KL; Pacheco Mda S; da Gama de Souza LN
J Gastrointest Cancer; 2016 Sep; 47(3):278-86. PubMed ID: 27146043
[TBL] [Abstract][Full Text] [Related]
4. High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.
Malfettone A; Silvestris N; Saponaro C; Ranieri G; Russo A; Caruso S; Popescu O; Simone G; Paradiso A; Mangia A
J Cell Mol Med; 2013 Aug; 17(8):1025-37. PubMed ID: 23991686
[TBL] [Abstract][Full Text] [Related]
5. Circulation of progenitor cells in obese and lean colorectal cancer patients.
Bellows CF; Zhang Y; Chen J; Frazier ML; Kolonin MG
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2461-8. PubMed ID: 21930958
[TBL] [Abstract][Full Text] [Related]
6. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer.
Mao Y; Feng Q; Zheng P; Yang L; Zhu D; Chang W; Ji M; He G; Xu J
Int J Cancer; 2018 Nov; 143(9):2271-2280. PubMed ID: 29873076
[TBL] [Abstract][Full Text] [Related]
7. High tumor mast cell density is associated with longer survival of colon cancer patients.
Mehdawi L; Osman J; Topi G; Sjölander A
Acta Oncol; 2016 Dec; 55(12):1434-1442. PubMed ID: 27355473
[TBL] [Abstract][Full Text] [Related]
8. Aberrant mast-cell differentiation in mice lacking the stem-cell leukemia gene.
Salmon JM; Slater NJ; Hall MA; McCormack MP; Nutt SL; Jane SM; Curtis DJ
Blood; 2007 Nov; 110(10):3573-81. PubMed ID: 17644741
[TBL] [Abstract][Full Text] [Related]
9. Mast cells and inflammation-associated colorectal carcinogenesis.
Tanaka T; Ishikawa H
Semin Immunopathol; 2013 Mar; 35(2):245-54. PubMed ID: 22993030
[TBL] [Abstract][Full Text] [Related]
10. Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer.
Song X; Xie D; Tan F; Zhou Y; Li Y; Zhou Z; Pei Q; Pei H
Aging (Albany NY); 2021 Aug; 13(16):20609-20628. PubMed ID: 34438367
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating mast cells in colorectal cancer as a poor prognostic factor.
Wu X; Zou Y; He X; Yuan R; Chen Y; Lan N; Lian L; Wang F; Fan X; Zeng Y; Ke J; Wu X; Lan P
Int J Surg Pathol; 2013 Apr; 21(2):111-20. PubMed ID: 22649166
[TBL] [Abstract][Full Text] [Related]
12. The critical role of mast cell-derived hypoxia-inducible factor-1α in regulating mast cell function.
Liang X; Yin G; Ma Y; Xu K; Liu J; Li J
J Pharm Pharmacol; 2016 Nov; 68(11):1409-1416. PubMed ID: 27671226
[TBL] [Abstract][Full Text] [Related]
13. Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C.
Song F; Zhang Y; Chen Q; Bi D; Yang M; Lu L; Li M; Zhu H; Liu Y; Wei Q; Qin H; Li J
Oncogene; 2023 Jan; 42(3):209-223. PubMed ID: 36402931
[TBL] [Abstract][Full Text] [Related]
14. Mast cells in colorectal neoplasias and premalignant disorders.
Lachter J; Stein M; Lichtig C; Eidelman S; Munichor M
Dis Colon Rectum; 1995 Mar; 38(3):290-3. PubMed ID: 7882795
[TBL] [Abstract][Full Text] [Related]
15. A Higher Frequency of CD14+ CD169+ Monocytes/Macrophages in Patients with Colorectal Cancer.
Li C; Luo X; Lin Y; Tang X; Ling L; Wang L; Jiang Y
PLoS One; 2015; 10(10):e0141817. PubMed ID: 26509874
[TBL] [Abstract][Full Text] [Related]
16. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
17. Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages.
Toor SM; Khalaf S; Murshed K; Abu Nada M; Elkord E
J Immunol Res; 2020; 2020():9678168. PubMed ID: 32626789
[TBL] [Abstract][Full Text] [Related]
18. The role of FKBP51 in the prognosis of ulcerative colitis-associated colorectal cancer.
Xia Z; Zhang G; Wang C; Feng Y
Adv Med Sci; 2021 Mar; 66(1):89-97. PubMed ID: 33461100
[TBL] [Abstract][Full Text] [Related]
19. Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis?
Georgin-Lavialle S; Le Saché-de Peufeilhoux L; Martin L; Soucie E; Bruneau J; Barete S; Dubreuil P; Bodemer C; Hermine O; Lhermitte L
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):967-71. PubMed ID: 23763569
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
